Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Sp1 links CD46 to CD4 T cell metabolic fitness, survival, and retroviral control.

Created on 11 Jul 2026

Authors

Parul Singh, Luopin Wang, Pavitra Ramdas, Shyaman M Jayasundara, Gaelle Le Friec, Natalia Kunz, Prakriti Mudvari, Erin E West, Ayden Case, Nicolas S Merle, Jack A Bibby, Henrik Hasle, Eli A Boritz, Majid Kazemian, Claudia Kemper

Published in

Science immunology. Volume 11. Issue 121. Pages eaeb5857. Jul 10, 2026. Epub Jul 10, 2026.

Abstract

CD46, a human-specific complement receptor, regulates gene programs essential for T helper 1 (TH1) cell differentiation, yet how it exerts direct transcriptional control remains unclear. We show that the CD46 signaling domain cytoplasmic tail 1 (CYT-1) engages the transcription factor Sp1 in human CD4 T cells to dynamically modulate Sp1-DNA interactions. Beyond promoting TH1 cell induction, CD46-Sp1-controlled programs support naive CD4 T cell survival by maintaining nutrient transporter expression and suppressing the intrinsic caspase 9-caspase 3 apoptotic pathway. The CD46-Sp1 axis also restrains HIV transcription in infected CD4 T cells in vitro. Disruption of CYT-1-Sp1-regulated programs identifies T cells from individuals with HIV who exhibit incomplete viral suppression during antiretroviral therapy. Together, these findings define a human-specific transcriptional mechanism linking complement signaling to metabolic adaptation, apoptosis regulation, and antiviral defense, highlighting an unexpected role for CD46 in coordinating T cell homeostasis and host protection.

PMID:
42430443
Bibliographic data and abstract were imported from PubMed on 11 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement